GlassScriptPhysician profile
Jennifer Thompson
NPI 1386801900
$1,530.82
in general payments reported to CMS, 2019-2025
24 companies · $281 in 2025
The $281 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $927 · 2022: $293 · 2023: $30.32 · 2025: $281.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $311.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $311.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $159.27 | 2021-2025 | Arexvy, Shingrix |
| Novo Nordisk INC | $139.32 | 2021-2022 | |
| Lundbeck LLC | $136.34 | 2025 | Vyepti |
| Astellas Pharma US INC | $121.92 | 2021 | |
| Abbvie INC. | $121.78 | 2021-2022 | |
| Lilly USA, LLC | $113.97 | 2021 | |
| Abiomed | $99.65 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $89.81 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $85.16 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $69.43 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $49.04 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $46.58 | 2021 | |
| Bardy Diagnostics, INC. | $38.63 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $36.21 | 2021 | |
| Novartis Pharmaceuticals Corporation | $33.00 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $30.32 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Amgen INC. | $29.12 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $26.60 | 2022 | |
| Tonix Medicines, INC. | $24.26 | 2025 | Tonmya |
| Ironwood Pharmaceuticals, INC | $21.77 | 2021 | |
| Pfizer INC. | $18.35 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.04 | 2021 | |
| Sanofi-Aventis U.S. LLC | $12.57 | 2022 | |
| Dexcom, INC. | $11.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.